TruthArchive.ai - Related Video Feed

Cancer is presented as highly preventable and not solely a genetic disease. The speaker cites research suggesting that higher blood sugar speeds tumor growth, while lower blood sugar slows it, asserting an undeniable link between metabolic state and cancer progression. They note that the transition from a normal cell to a cancer cell does not happen overnight and ask how tumors grow so rapidly, go out of control, and resist easy destruction. A non-toxic approach to managing cancer is proposed: simultaneously restricting two fuels that tumors rely on—glucose and the amino acid glutamine. Glucose circulates in the bloodstream from the foods we eat, and glutamine is an essential nutrient for rapidly dividing cells. By adopting a low-carbohydrate diet and engaging in water-only fasting, a person can achieve nutritional ketosis. The core claim is that tumor cells have defective mitochondria and are dependent on glucose and glutamine for growth and survival, making them vulnerable when these fuels are restricted. The strategy is to replace glucose and glutamine with ketone bodies, thereby selectively marginalizing tumor cells and causing their gradual death. As this occurs, the tumor’s blood vessels disappear, and the body dissolves the remaining tumor tissue. The speaker emphasizes that understanding what causes mitochondrial dysfunction is central to cancer management and that keeping mitochondria healthy is crucial. To maintain mitochondrial health, the recommended practices include vigorous exercise, periods of water-only fasting, and a reduction in the consumption of highly processed carbohydrates. The overarching argument frames cancer control as a metabolic intervention—starving cancer cells of their preferred fuels and supporting mitochondrial integrity through lifestyle choices—rather than relying on conventional toxic therapies. The description highlights a sequence in which fuel restriction leads to metabolic stress on tumor cells, followed by vascular regression within tumors and eventual dissolution, framed as the body's response to diminished glucose and glutamine availability.

Speaker discusses glioblastoma and related pediatric pineoblastomas, stating they are devastating and among the worst cancers. He notes that, based on long-term research and Otto Warburg’s observations, neoplastic cells inside a glioblastoma predominantly use a fermentation metabolism to generate energy, meaning they generate energy without the use of oxygen. He says glioblastoma multiforme was a term used because the cells are highly dysmorphic, but according to his metabolic hypothesis, the origin of the disease arises from damage to cellular respiration, causing all cells to ferment regardless of appearance. All neoplastic cells in glioblastoma are said to use energy without oxygen, derived from two fuels: glucose and glutamine. The speaker highlights stalled survival statistics for glioblastoma, remarking that despite modern scientific advances, there has been no major improvement in keeping people alive. He argues that cancer is not a genetic disease but a metabolic one, and criticizes continued irradiation of the brain in patients with these tumors. He claims published evidence shows that irradiating the brain frees up metabolic fuels glucose and glutamine, driving tumor growth, and that treating glioblastoma with radiation worsens outcomes. He asserts that the brain’s radiation raises blood sugar, stimulates the head to warm, and, along with high-dose steroids that further raise sugar, disrupts neural-glial connections and frees glutamine, leading to rapid demise of many patients. He says the death from glioblastoma is highly reproducible across major medical schools worldwide, and questions why such treatment is used. The speaker cites Pablo Kelly in England, who chose no radiation, no chemotherapy, and no conventional treatment after surgery, suggesting surgery is an essential tool for debulking. He emphasizes that surgical debulking combined with metabolic therapy can shrink the tumor and that metabolic therapy restricts the availability of glucose and glutamine without disturbing the tumor microenvironment. He claims this approach allows patients to live far longer with better quality of life, proposing a shift away from targeting mutations toward a metabolic theory. he outlines a management strategy: surgery to remove much of the tumor, then metabolic therapy to reduce glucose and glutamine, followed by drugs and procedures to further target these fuels. He argues for transitioning patients to nutritional ketosis, lowering blood sugar, elevating ketone bodies (which tumor cells cannot use), thereby marginalizing the tumor, and using additional interventions to target glucose and glutamine. The speaker concludes by asking why such an approach is not implemented, inviting readers to review survival statistics and cancer metabolism to understand why current treatments fail.

Speaker 0 explains that most current treatments are highly toxic, including radiation, chemotherapy, and crude surgery. In contrast, metabolic oncology uses therapy that is diet-based and may include other compounds that block fermentation pathways. This approach reportedly has no side effects and offers numerous benefits for overall metabolic health, including reducing inflammation, improving stem cell function, promoting DNA repair, and helping manage oxidative stress, with a wide range of positive effects described. Speaker 1 concurs, noting that there is a return to the origins of many diseases. He points to systemic inflammation and chronic exposure to various chemicals as contributing factors. When these elements are combined, they purportedly lead to chronic diseases such as diabetes, cardiovascular disease, cancer, and dementia. He adds that much of these conditions involve disturbed energy and disrupted metabolic homeostasis.

The speaker presents a theory of cancer origin and management centered on the idea that cancer cells are cells hovering near death and severely limited in their capacity for survival, in contrast to normal cells in different organs that can flexibly generate and use energy. The core claim is that cancer cells are tightly linked to fermentation-based energy, whereas healthy cells have broader metabolic options. Based on this framework, the speaker outlines a staged strategy to “kill cancer cells” by manipulating energy metabolism. First, the speaker advises reducing the glucose–ketone index (GKI) to close to 2.0 or below 1.0, asserting that this shift will begin to kill cancer cells. To achieve this, the speaker recommends a zero-carbohydrate diet for about ten days, with monitoring to observe the GKI stair-stepping downward in the right direction. The implication is that lowering GKI shifts the body's energy utilization away from glucose toward alternative fuels in a way that pressures cancer cells. Next, after the initial dietary period, the speaker suggests transitioning to water-only fasting. During or after this fasting phase, a “battery of drugs” is introduced—specifically repurposed drugs described as pounding the glutamine pathway and further lowering glucose. The speaker asserts that these tumor cells are “toast” under this dramatic metabolic change, implying that cancer cells cannot cope with the combined stress on glucose and glutamine metabolism. The speaker goes on to claim that, in addition to direct metabolic pressure on tumor cells, healthy body cells compete with tumor cells, effectively starving the cancer cells even more. A further claimed mechanism is “autolytic cannibalism,” where the body reportedly targets tumor cells and uses them as fuel for healthier cells, enhancing the body's ability to combat cancer. The speaker characterizes this process as “evolutionary biology in action,” emphasizing a natural, systemic shift in energy use and cellular competition that favors normal cells over cancer cells. Overall, the presentation outlines a sequential, metabolism-driven approach to cancer treatment: first drive the GKI downward through a zero-carb diet, then implement water-only fasting with a combination of repurposed drugs to suppress glutamine utilization and further reduce glucose availability, with the expectation that tumor cells will be overwhelmed while healthy cells survive and even utilize tumor cells for fuel in a process described as autolytic cannibalism and competitive starvation.

Ivermectin and mebendazole may disrupt cancer cell metabolism and glioma growth. Ivermectin blocks tumor cells from generating energy through oxidative phosphorylation, inhibits cancer stem cells, and disrupts glucose uptake. Mebendazole interferes with microtubule formation in glioma cells, induces apoptosis, and crosses the blood brain barrier. These drugs are backed by emerging science and used in terrain-based cancer protocols. When combined with fasting, oxygen therapy, and targeted nutrition, they may help flip the metabolic switch and support the body's natural healing power. The speaker claims this is how they overcame stage four brain cancer. The speaker is offering their complete healing protocol for free to those who comment "protocol."

Colleagues in Istanbul showed that chemotherapies at much lower dosages can be even more therapeutically powerful when you're in nutritional ketosis. You don't have to get rid of a lot of these different procedures that we have today. I'm just saying radiation for brain cancer. I'm not saying radiation for lung or some of the other cancers. If can shrink those tumors down and make them very weak and vulnerable, a surgical procedure, a radiation procedure, even low dose chemo could come in. And even immunotherapy, if you took a big tumor and shrunk it down to a small nub and it's resistant to a lot of the things, they all have to share something in common for them to survive this path. That might be an immunotherapy could come in because they're gonna target whatever all of them have together, and you could possibly get rid of it that

In 1931, a doctor named Otto Warburg purportedly identified the real root of cancer and suggested that the world ignored him. According to the speaker, Warburg won the Nobel Prize for discovering something that should have transformed cancer treatment forever. The core claim presented is that cancer does not begin with bad genes; it begins when cells can no longer use oxygen to produce energy. Warburg purportedly discovered that cancer cells ferment sugar even in the presence of oxygen, a phenomenon referred to as the Warburg effect. The speaker emphasizes that, despite this theory, cancer treatment today is still approached as if cancer is solely genetic, implying a disconnect between Warburg’s findings and common medical practice. The speaker asserts personal involvement with Warburg’s theory. He states that he was diagnosed with a grade four diffuse astrocytoma brain cancer and applied Warburg’s theory in his own life. According to the speaker, this involved completely cutting sugar from his diet and entering therapeutic ketosis. He also mentions using oxygen therapy and structuring his life around one primary objective: restoring mitochondrial function. He claims that, as a result, he is now cancer free. The narrative frames Warburg’s insight as correct all along, and the speaker indicates that he had to discover this for himself rather than being told about it. Additionally, the speaker offers an actionable resource for the audience. He states that if listeners want the exact protocol he followed, they should comment “protocol” below, and he will send the protocol to them for free. The message closes with an expression of gratitude and affection, thanking the audience and expressing love for them all. Key points highlighted include: Warburg’s assertion that cancer is a metabolic disease linked to cellular energy production rather than solely a genetic issue; the Warburg effect, where cancer cells ferment sugar even when oxygen is available; a critique of current cancer treatment as if it is exclusively genetic; a personal testimony of achieving cancer remission through sugar restriction, therapeutic ketosis, oxygen therapy, and mitochondrial restoration; and an invitation to receive the exact protocol by commenting the requested keyword.

Speaker 1 was deemed inoperable, incurable, palliative, and terminally ill, with a couple of months to live without treatment. Speaker 0 was also terminal after cancer spread to the liver and lungs and did not want to undergo chemo again. Metabolic therapy can manage the disorder and correct other problems like diabetes, high blood pressure, and hypertension, so you get healthier as you degrade your tumor. Speaker 0's cancer levels went down to 0.05, which is almost nothing, and was cancer-free by December 2020. Speaker 1 is doing really well fifteen to eighteen months later. Speaker 3's wife had stage four cancer and was cancer-free a year later using metabolic therapies. Fasting and metabolic therapy combined with chemo can lower chemo dosages while maintaining therapeutic efficacy. If you want to live and get healthy, you do metabolic therapy, but "they" will not allow the entire system to change.

If I had cancer, the first step would be to stop taking carbs and lower the Glucose Ketone Index (GKI). A GKI closer to 2.0 or below 1 starts killing cancer cells. A zero-carb diet for about ten days helps lower GKI, followed by water-only fasting. The brain is addicted to glucose, so a zero-carb diet helps lower that addiction slowly. Once the GKI is around five or seven, the next step is water-only fasting. While in water-only fasting and maintaining a low GKI, repurposed drugs are used to further lower glucose and hammer glutamine. Tumor cells can't handle this dramatic change and often die. The body cells compete directly with the tumor cells, starving them further. The body goes after the tumor cells and uses them for fuel, called autolytic cannibalism.

If the speaker had cancer, the first step would be to stop taking carbs and lower the Glucose Ketone Index (GKI). A GKI closer to 2.0 or below 1 starts killing cancer cells. Due to the difficulty, a zero-carb diet is recommended for about ten days to gradually lower the GKI. Once the GKI is around 5 or 7, the next step is water-only fasting. This gradual approach is easier on the body than abruptly stopping food intake. The brain is addicted to glucose, so a zero-carb diet helps lower that addiction slowly. During water-only fasting with a low GKI, repurposed drugs are introduced to further lower glucose and target glutamine. This dramatic change can cause tumor cells to die. Healthy body cells compete with tumor cells, causing further starvation. The body may also go after the tumor cells and use them as fuel, a process called autolytic cannibalism.

The speaker asserts that brain radiation in brain cancer patients releases significant glucose and glutamine, reducing survival rates, typically to under five years. Despite repeated publication of these findings, radiation continues to be used. The speaker argues that brain cancer patients should be aware that brain irradiation significantly reduces long-term survival, even with a ketogenic diet. While not dismissing all treatments, like low-dose temozolomide with metabolic therapy, the speaker adamantly states that brain radiation should never be used on brain tumor patients, as it worsens the condition. Speaker 1 confirms his wife experienced radiation necrosis from brain radiation.

Speaker 1 states they are not telling people to avoid chemotherapy. Research indicates that when patients are in nutritional ketosis with a glucose ketone index of 2.0 or below, lower doses of chemotherapy can be more therapeutically powerful. Speaker 1 suggests that radiation may be beneficial for some cancers, like brain cancer, to shrink tumors. After shrinking tumors and making them vulnerable, surgical procedures, radiation, low-dose chemo, or even immunotherapy could be more effective. Immunotherapy may target what the remaining cells have in common, potentially eliminating them.

Cancer originated from damage to mitochondria, forcing the cell into a fermentation mechanism to survive. The two fermentation fuels that drive the majority, if not all cancers, are a sugar fermentation and an amino acid fermentation. Without glucose and glutamine, no cancer cell can survive. All of the major chronic diseases that we are currently suffering from are the result of excessive amounts of carbohydrates in the diet. The very treatments that are used, radiation as well as temozolomide, they free up massive amounts of glucose and glutamine in the tumor microenvironment, making long term survival very, very rare. I published a clear paper on how the radiation breaks apart the glutamine–glutamate cycle in the brain, freeing up massive amounts of glutamine. Steroids they give these patients increases blood sugar. The two fuels necessary for causing cancer cells to grow out of control are made available in abundant quantities by the very treatments that we're doing to these patients. And cancer cells can't burn ketones or fats. They only can burn glucose and glutamine. And actually, we still don't know the mechanism by which ketogenic diets block epilepsy, but it became crystal clear as how this diet could stop cancer growth.

Pablo Kelly was from Devon, England, and had a glioblastoma, the worst of the worst. He was all over the Devon press and constantly sent me articles from England—Man rejects standard of care. He had the tumor removed, but it was said to be inoperable; even with radiation and chemo, they warned he might live nine, maybe twelve months at most. Pablo came from a family that doesn’t dabble in conventional medicine and was more holistic. He emailed me in 2014 saying he wanted to try this metabolic thing. He rejected chemo and radiation. They said it wasn't surgically capable of being completely removed anyway. He did this metabolic therapy, alongside a very low-carbohydrate paleo diet with avocados and fish oil. Two and three years go by, he emails me. I said, jeez, Pablo, I thought you would have been dead.

Foods with a low glycemic index are advised to keep a steady glucose level; 'a banana, very high in glycemic index' causes an immediate spike. I built that calculator for brain cancer patients; now it's powerful for all cancers. We place the cancer patient in the low glucose ketone index. We get them down in there. Then we add 'glutamine targeting drugs' to polish off tumors or dormant them. Now young people, '30, 20 year olds,' ask 'what's the GKI?' They’re into weightlifting and see they can enter a 'paleolithic zone' themselves. 'Yes, that will prevent cancer because you can't get cancer if your mitochondria are healthy.' You're in a 'paleolithic zone' where our ancestors rarely have ever got cancer.

The speaker expresses frustration that cancer patients seeking metabolic therapy are turned away by top medical schools due to a perceived lack of evidence. Patients are left wondering where to find such treatment. The speaker does not have a clinic and is not a medical doctor. Many practitioners fear losing their licenses if they deviate from the standard of care. The speaker questions why the standard of care is so rigid and why major cancer centers like Dana Farber, MD Anderson, Sloan Kettering, Moffitt, and Fred Hutch are not actively researching and implementing metabolic therapies.

To manage cancer without toxicity, we can restrict the two fuels that drive tumor growth—glucose and glutamine—while transitioning the body to use ketones and fatty acids, which tumors cannot utilize. By implementing calorie restriction to lower blood sugar and using specific drugs to target glutamine, we can effectively limit these fuels. Humans have evolved to be in a state of nutritional ketosis for most of our existence, relying on low carbohydrate intake. Normal cells can utilize ketone bodies for energy due to their healthy mitochondria, while tumor cells cannot. By replacing glucose and glutamine with ketones, we can gradually marginalize tumor cells, leading to their death as blood vessels diminish and the body clears them away.

The speaker asserts that cancer is a mitochondrial metabolic disease, not a nuclear one, and that recognizing this will drastically reduce cancer death rates. While cancer may never be completely eradicated, it can be managed by restricting the fuels that cancer cells need and optimizing mitochondrial health through diet and lifestyle. If the focus remains on the nucleus instead of the mitochondria, cancer rates will continue to rise, affecting one out of two people.

The speaker describes cancer as an autonomous entity that hides, like a virus, by blocking expression through genomic sequencing. Low-dose chemotherapy or low-dose radiation (SBRT) can be used to stress the cancer and "smoke it out," exposing it to the immune system. The speaker advocates for a simultaneous, multi-pronged approach: expose the tumor, activate natural killer (NK) and T cells (using a "BioShield" molecule to upregulate them and drive memory T cells), educate T cells with a vaccine, activate macrophages, and suppress suppressors. This approach aims to use the tumor as a vaccine by educating T cells to recognize foreign molecules. The speaker claims this protocol is done entirely on an outpatient basis, without the typical suffering associated with conventional cancer therapy. They report bladder cancer patients in complete remission for nine years using this method.